个性化文献订阅>期刊> Expert opinion on investigational drugs
 

Betahistine: whats new on m the agenda?

  作者 Barak, N  
  选自 期刊  Expert opinion on investigational drugs;  卷期  2008年17-5;  页码  795-804  
  关联知识点  
 

[摘要]

Background: Betahistine is an orally administered, centrally acting histamine H, receptor agonist with partial H-3 antagonistic activity and no H-2-bincling effects. In the past betahistine was clinically studied mainly as a vasodilator for conditions such as cluster headaches, vascular dementia and Meniere's disease, for which it is still used. in recent years, histamine was found to be a key neurotransmitter in the regulation of feeding behavior. Objective: To provide a review of the developmental history and current research interests of betahistine. Methods: All reports of betahistine use in animals and humans were retrieved and reviewed. Results/conclusion: The unique pharmacologic properties of betahistine point to its potential future use as an antiobesity agent.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内